Searchable abstracts of presentations at key conferences in endocrinology

ea0049s1.1 | Clinical Updates in Hypoparathyroidism | ECE2017

Congenital hypoparathyroidism

Linglart Agnes

The most common causes of hypoparathyroidism in children are the lack of or the impaired development of the parathyroid glands due to genetic/chromosomal alterations and the abnormal signaling of the Ca(2+)-sensing receptor (CaSR). The latter refers to autosomal dominant hypocalcemia (ADH) mainly caused by heterozygous activating mutations in CASR encoding CaSR (ADH type 1), and exceptionally caused by activating mutations of GNA11 encoding the Gq/11 protein (ADH ty...

ea0081yi5 | Young Investigator Awards | ECE2022

Pseudohypoparathyroidism: focus on neonatal features, preliminary data from a retrospective analysis of a large cohort of patients

Del Sindaco Giulia , Pagnano Angela , Berkenou Jugurtha , Rothenbuhler Anya , Arosio Maura , Linglart Agnes , Mantovani Giovanna

Since the first description of pseudohypoparathyroidism (PHP) a remarkable clinical variability was observed. In 2016 a new classification of this group of diseases have been published by the European Network on PHP and related disorders, proposing “inactivating PTH/PTHrP signaling disorder” (iPPSD) as a new term that encompasses all the clinical entities. PHP and related disorders vary in clinical presentation and disease severity, and clinical features usually deve...

ea0090oc8.5 | Oral Communications 8: Calcium and Bone | ECE2023

A vitamin D receptor antagonist as a potent and safe treatment for Idiopathic Infantile Hypercalcemia

Rovito Daniela , Lutzing Regis , Keime Celine , Metzger Daniel , Linglart Agnes , Laverny Gilles

Idiopathic Infantile Hypercalcemia (IIH) is a rare inborn form of severe vitamin D hypersensitivity, with an estimated incidence of 1:33.000 live birth and a high degree of misdiagnosis. Since the identification of CYP24A1 loss-of-function variants inducing IIH in 2011, over 41 pathogenic variants have been described, and represent the major genetic drivers of IIH1. CYP24A1 encodes the main catalytic hydroxylase of the bioactive form of vitamin D (1,25D3). Upon bind...

ea0022oc6.3 | Bone | ECE2010

Six novel mutations in 25-hydroxyvitamin D3 1α hydroxylase gene in patients with pseudovitamin D deficiency rickets

Abeguile Genevieve , Coudray Nadia , Richard Nicolas , Linglart Agnes , Kottler Marie-Laure

Pseudovitamin D deficiency rickets also called vitamin D-deficiency rickets type 1 (VDDR 1) is an autosomal recessive disorder in which 25-hydroxyvitamin D3 1 alpha-hydroxylase gene (CYP27B1) is deficient. VDDR1 is characterized by hypocalcemia,hypophosphatemia elevated serum PTH levels and low or undetectable serum concentrations of 1,25(OH)2D.We screened for mutations CYP27B1 in ten individuals from seven unrelated families wit...

ea0090oc8.1 | Oral Communications 8: Calcium and Bone | ECE2023

Clinical picture of early infancy PTH-resistance syndromes: is it time to improve diagnostic criteria?

Del Sindaco Giulia , Pagnano Angela , Berkenou Jugurtha , Ferrante Emanuele , Rothenbuhler Anya , Arosio Maura , Mantovani Giovanna , Linglart Agnes

Since the first description of inactivating PTH/PTHrP signaling disorders (iPPSDs, historically named pseudohypoparathyroidism (PHP)) a remarkable clinical variability was observed, especially in clinical presentation, which seems to be age-dependent. The main clinical features, including PTH resistance, brachydactyly and short stature, develop during mid and late childhood, whilst minor clinical features such as a round face, rapid weight gain and subclinical hypothyroidism a...

ea0090p576 | Calcium and Bone | ECE2023

Hypercalcitoninemia in a large cohort of adult and paediatric patients with PTH-resistance syndromes

Cremaschi Arianna , Del Sindaco Giulia , Pagnano Angela , Dolci Alessia , Contarino Andrea , Ferrante Emanuele , Arosio Maura , Linglart Agnes , Mantovani Giovanna

Inactivating PTH/PTHrP signaling disorders (iPPSDs, historically named pseudohypoparathyroidism (PHP)) are a group of rare disorders associated with resistance to parathormone (PTH) and other hormones due to impaired hormonal signaling via G protein coupled receptors. Hypercalcitoninemia has been reported in these patients, however very few reports are available. The aim of this study was to further investigate the prevalence and characteristics of hypercalcitoninemia in both ...

ea0049gp45 | Bone & Calcium Homeostasis 2 | ECE2017

Methylation patterns at the novel DMR of GNAS (GNAS-AS2) in pseudohypoparathyroidism 1B (PHP1B or iPPSD3) subtypes

Hanna Patrick , Rochtus Anne , Jueppner Harald , Mackay Deborah , Francou Bruno , Bouligand Jerome , Mantel Anne , Anagnostou Elli , Gaillard Dominique , Linglart Agnes

PHP1B -iPPSD3 per the new proposed classification- is a rare disorder characterized in most patients by proximal tubular resistance to PTH resulting in hypocalcemia, hyperphosphatemia and elevated PTH. Loss-of-methylation (LOM) at the Differentially Methylated Region (DMR) at GNAS exon A/B occurs in all PHP1B patients, but methylation changes at other DMRs within GNAS occur in some familial and most sporadic PHP1B cases. All patients with autosomal dominant PHP1B (AD-...

ea0035p140 | Calcium and Vitamin D metabolism | ECE2014

Prospective evaluation of endocrine complications in adults with X-linked hypophosphatemic rickets

Kamenicky Peter , Boros Emese , Rothenbuhler Anya , Brailly Sylvie , Silve Caroline , Souberbielle Jean-Claude , Chanson Philippe , Linglart Agnes

Objectives: X-linked hypophosphatemic Rickets (XLHR) is characterized by phosphate wasting and decreased production of 1,25OH-vitamin D, due, in most patients, to elevated FGF23 and PHEX mutation. In children, the disease has been extensively studied because of the devastating presentation of rickets, teeth abcesses, and growth retardation. In adults, however, metabolic complications, such as hyperparathyroidism or consequences on glucose and lipid metabolism of FGF23 excess, ...

ea0022h2.2 | Oral Communications Highlights 2 | ECE2010

Human recombinant GH replacement therapy in children with pseudohypoparathyroidism type Ia and GH deficiency: first study on the effect on growth

Mantovani Giovanna , Ferrante Emanuele , Linglart Agnes , Cappa Marco , Cisternino Mariangela , Maghnie Mohamad , Beck-Peccoz Paolo , Spada Anna

Pseudohypoparathyroidism (PHP) refers to a heterogeneous group of rare metabolic disorders characterized by hypocalcemia and hyperphosphatemia due to PTH resistance. Heterozygous loss of function mutations in the gene encoding the alpha-subunit of Gs (GNAS) inherited from the mother lead to PHP type Ia. PHP type Ia (PHP-Ia) is a disease in which the physical features (short stature, obesity, round face, brachydactyly and subcutaneous ossifications) that constitute Albri...

ea0081p548 | Calcium and Bone | ECE2022

Disease characteristics, disability, and quality of life in adult HPP patients with muscular symptoms and pain without skeletal manifestations – a cross-sectional analysis from the Global HPP Registry

Dahir Kathryn M. , Angel Martos-Moreno Gabriel , Linglart Agnes , Petryk Anna , Kishnani Priya S. , Rockman-Greenberg Cheryl , Martel Samantha E. , Ozono Keiichi , Hogler Wolfgang , Seefried Lothar

Background: Hypophosphatasia (HPP) is a rare, inherited metabolic disease caused by deficient activity of tissue nonspecific alkaline phosphatase (TNSALP).Methods: Baseline/pretreatment data from the Global HPP Registry were analyzed to compare HPP disease burden between adults (≥18 years of age) with skeletal manifestations (history of rickets, biopsy-proven osteomalacia, recurrent or poorly healing fractures/pseudofractures, etc; Skeletal group) ...